Literature DB >> 15142365

A case of thymic enlargement in hyperthyroidism in a young woman.

Tomoatsu Nakamura1, Masami Murakami, Hisashi Horiguchi, Shoichiro Nagasaka, Shun Ishibashi, Masatomo Mori, San-e Ishikawa.   

Abstract

We present the case of a 24-year-old woman with thymic enlargement accompanied by hyperthyroidism. An x-ray incidentally detected her thymic enlargement and the size was estimated to be 226 cm(3) by computed tomography (CT) using three-dimensional analysis. Physical examination revealed a soft diffuse goiter, increased sweating and restlessness; thyroid function tests showed hyperthyroidism. Because the possibility of a thymoma could not be completely excluded, a mediastinal biopsy via a supracervical approach was done that determined the specimen was composed of normal thymic tissue. Together with these findings, the patient's thymic enlargement was likely to be consistent with true thymic hyperplasia. Moreover, we have demonstrated the presence of the thyrotropin (TSH) receptor in her thymus using reverse transcription-polymerase chain reaction (RT-PCR). She was treated with methimazole, resulting in the resolution of not only the thyroid dysfunction but also thymic enlargement. Thymic enlargement has often been recognized as a complication of hyperthyroidism. However, the pathophysiologic mechanisms underlying these conditions remain obscure. Our result raises the speculation that the thymus is also a target organ of autoimmune attack as are the orbital and fibroblasts, which lead to Graves' ophthalmopathy and pretibial dermopathy, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15142365     DOI: 10.1089/105072504323030979

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  9 in total

Review 1.  Thymic hyperplasia in patients with Graves' disease.

Authors:  M Dalla Costa; F A Mangano; C Betterle
Journal:  J Endocrinol Invest       Date:  2014-08-23       Impact factor: 4.256

2.  Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy.

Authors:  Ismail Sari; Omer Binicier; Merih Birlik; Servet Akar; Erkan Yilmaz; Aydanur Kargi; Fatos Onen; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2008-09-23       Impact factor: 2.631

3.  Thymic hyperplasia in Graves' disease.

Authors:  Debora Lucia Seguro Danilovic; Regina Matsunaga Martin; Pedro Caruso; Suemi Marui
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 4.  Incidentally Visualization of the Thymus on Whole-Body Iodine Scintigraphy: Report of 2 Cases and Review of the Latest Insights.

Authors:  Mahdi Haghighatafshar; Farinaz Farhoudi
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

5.  Thymic Involution After Radioiodine Therapy for Graves Disease: Relationships With Serum Thyroid Hormones and TRAb.

Authors:  Megumi Jinguji; Masayuki Nakajo; Masatoyo Nakajo; Chihaya Koriyama; Takashi Yoshiura
Journal:  J Endocr Soc       Date:  2017-06-05

6.  Hyperplastic thymus with increased angiogenesis is correlated with elevated serum thyroglobulin level in differentiated thyroid cancer patients with TENIS syndrome.

Authors:  Guangjian Zhang; Rui Gao; Yuanbo Wang; Yan Liu; Juan Li; Xi Jia; Yiqian Liang; Aimin Yang
Journal:  Oncotarget       Date:  2017-12-15

7.  The coexistence of hypercalcemia, osteoporosis and thymic enlargement in graves' disease: a case report.

Authors:  Dandan Yan; Yanjun Xu; Lian-Xi Li
Journal:  BMC Endocr Disord       Date:  2020-06-30       Impact factor: 2.763

8.  Graves' Patient with Thymic Expression of Thyrotropin Receptors and Dynamic Changes in Thymic Hyperplasia Proportional to Graves' Disease Activity.

Authors:  Young Shin Song; Jae-Kyung Won; Mi Jeong Kim; Ji Hyun Lee; Dong-Wan Kim; June-Key Chung; Do Joon Park; Young Joo Park
Journal:  Yonsei Med J       Date:  2016-05       Impact factor: 2.759

9.  Managing thymic enlargement in Graves' disease.

Authors:  C Kamath; J Witczak; M A Adlan; L D Premawardhana
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-01-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.